Literature DB >> 1865369

Inhibitory influence of the mesocortical dopaminergic neurons on their target cells: electrophysiological and pharmacological characterization.

R Godbout1, J Mantz, S Pirot, J Glowinski, A M Thierry.   

Abstract

Both dopaminergic (DA) and noradrenergic (NA) systems exert an inhibitory influence on the activity of prefrontal cortical neurons (PFC). As NA-containing fibers run close to the dorsal ventral tegmental area (VTA), electrical stimulation of the VTA might coactivate both DA and NA systems. In the present study extracellular recordings and microiontophoresis were used in anesthetized rats to analyze first whether the inhibitory cortical responses to VTA stimulation and DA application were mediated by DA or adrenergic receptors. Inhibitory responses elicited by DA application or VTA stimulation were observed in PFC output neurons identified by antidromic activation from subcortical structures. Both types of inhibitory effects were reversed by the DA antagonist sulpiride, but not by the adrenergic antagonists prazosin (alpha-1), yohimbine (alpha-2) or propranolol (beta). NA and the beta agonist isoproterenol inhibited the activity of PFC cells and these effects were antagonized by propranolol, but neither by prazosin and yohimbine nor by the DA antagonist sulpiride. Thus, the inhibitory influence of the mesocortical DA system in the PFC involves DA, but not NA, recognition sites. The DA receptor subtype mediating the inhibitory effects of VTA stimulation and DA application in the PFC was analyzed further. VTA- and DA-evoked inhibitory responses were antagonized by the D2 selective antagonists (-)-sulpiride, LUR 2366 and RIV 2093, but not by the D1 selective antagonist SCH23390. In addition, the DA-induced inhibitory response was mimicked by the selective D2 agonist LY 171555 but not by the selective D1 agonist SKF 38393. Surprisingly, haloperidol, which is also a potent D2 antagonist, failed to consistently block DA- and VTA-induced inhibitory effects. The present results indicate that the inhibition of PFC cells by mesocortical DA neurons is mediated via a subtype of DA receptors which is particularly sensitive to benzamides.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1865369

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  14 in total

1.  A neurocomputational theory of the dopaminergic modulation of working memory functions.

Authors:  D Durstewitz; M Kelc; O Güntürkün
Journal:  J Neurosci       Date:  1999-04-01       Impact factor: 6.167

2.  Dopamine terminals in the rat prefrontal cortex synapse on pyramidal cells that project to the nucleus accumbens.

Authors:  D B Carr; P O'Donnell; J P Card; S R Sesack
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

3.  The hippocampo-prefrontal pathway: a possible therapeutic target for negative and cognitive symptoms of schizophrenia.

Authors:  Ayan Ghoshal; P Jeffrey Conn
Journal:  Future Neurol       Date:  2015

4.  Brief dopaminergic stimulations produce transient physiological changes in prefrontal pyramidal neurons.

Authors:  Anna R Moore; Wen-Liang Zhou; Evgeniy S Potapenko; Eun-Ji Kim; Srdjan D Antic
Journal:  Brain Res       Date:  2010-11-06       Impact factor: 3.252

5.  Striatal neuronal activity and responsiveness to dopamine and glutamate after selective blockade of D1 and D2 dopamine receptors in freely moving rats.

Authors:  E A Kiyatkin; G V Rebec
Journal:  J Neurosci       Date:  1999-05-01       Impact factor: 6.167

6.  Mesocortical dopamine neurons operate in distinct temporal domains using multimodal signaling.

Authors:  Antonieta Lavin; Lourdes Nogueira; Christopher C Lapish; R Mark Wightman; Paul E M Phillips; Jeremy K Seamans
Journal:  J Neurosci       Date:  2005-05-18       Impact factor: 6.167

7.  Reward processing abnormalities in Parkinson's disease.

Authors:  Dimitrios Kapogiannis; Eric Mooshagian; Paul Campion; Jordan Grafman; Trelawny J Zimmermann; Kelsey C Ladt; Eric M Wassermann
Journal:  Mov Disord       Date:  2011-04-29       Impact factor: 10.338

Review 8.  Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction.

Authors:  Patricia S Goldman-Rakic; Stacy A Castner; Torgny H Svensson; Larry J Siever; Graham V Williams
Journal:  Psychopharmacology (Berl)       Date:  2004-04-30       Impact factor: 4.530

9.  Characterization of electrically evoked field potentials in the medial prefrontal cortex and orbitofrontal cortex of the rat: modulation by monoamines.

Authors:  Joanne Wallace; Rosanna K Jackson; Tanya L Shotton; Ishaana Munjal; Richard McQuade; Sarah E Gartside
Journal:  Eur Neuropsychopharmacol       Date:  2013-08-06       Impact factor: 4.600

10.  Analyzing short-term noise dependencies of spike-counts in macaque prefrontal cortex using copulas and the flashlight transformation.

Authors:  Arno Onken; Steffen Grünewälder; Matthias H J Munk; Klaus Obermayer
Journal:  PLoS Comput Biol       Date:  2009-11-26       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.